The influence of alloyed Sn on the chemistry of C 4 butene isomers, including 1-butene, cis -2-butene, and isobutene, chemisorbed on Pt(111) was investigated by temperature-programmed desorption (TPD), Auger electron spectroscopy (AES), and low-energy electron diffraction (LEED). Pt−Sn alloy chemistry was probed by investigation of two ordered surface alloys formed when Sn atoms were incorporated within the topmost layer on a Pt(111) substrate to form a (2 × 2) Sn/Pt(111) alloy with ϑ Sn = 0.25 and a (√3 × √3)R30° Sn/Pt(111) alloy with ϑ Sn = 0.33. Low-coverage states of chemisorbed 1-butene, cis -2-butene, and isobutene on Pt(111) have desorption activation energies of 17.5, 17, and 17 kcal/mol, respectively. These energies are reduced to 16, 15.5, and 15 kcal/mol on the (2 × 2) alloy and 13.5, 12, and 11 kcal/mol on the (√3 × √3)R30° alloy. Changing the surface Sn concentration from ϑ Sn = 0.25 to ϑ Sn = 0.33 causes a relatively larger decrease in the chemisorption bond strength of these alkenes, and we associate this with the importance of a pure Pt 3-fold site for strong alkene bonding. All three butenes undergo decomposition on Pt(111) during TPD which accounts for 50−60% of the chemisorbed monolayer. Alloying Sn into the surface causes a large reduction in the reactivity of the surface, and the fraction of the chemisorbed layer which decomposes is decreased to 3−7% on the (2 × 2) alloy, and no decomposition occurs on the (√3 × √3)R30° alloy. The strong reduction of decomposition on these two surface alloys may be due to the elimination of adjacent pure Pt 3-fold hollow sites. No large changes occur in the coverage of the chemisorbed monolayer of butenes in the presence of up to 33% of a monolayer of alloyed Sn, showing that the adsorption ensemble requirement for chemisorption of these alkenes on Pt(111) and the two Sn/Pt(111) alloys is at most a few Pt atoms. To the extent that alloying or direct Pt−Sn interactions occur in supported, bimetallic Pt−Sn catalysts, the chemistry reported here would lead to increased isobutene yields and decreased coking of the catalyst.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (1997) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: